Specialties
Reports that name this provider
- Clinical Trial Access in United Kingdom
- Part of Adult Drug Development Unit with Institute of Cancer Research. Internationally-leading group of over 100 specialist staff. Enrolls approximately 300 patients onto Phase I trials per year. Evaluates 50-60 trials annually, focusing on molecularly targeted and precision oncology agents. Treats 50,000 patients per year from the UK and internationally.
- Medical Technology in United Kingdom
- World's first centre to implement ARTemis online adaptive radiation therapy (OART). Operates CyberKnife since 2011 (4,000+ patients treated). Installed two Accuray Radixact linear accelerators. Participated in mRNA cancer vaccine clinical trials designated as Breakthrough Therapy.